Determinants of poor hypertension management in patients with ischaemic heart disease

Piotr Jankowski1, Kalina Kawecka-Jaszcz, Grzegorz Bilo

  • 1Department of Cardiology, Institute of Public Health, Jagiellonian University Medical College, Kraków, Poland.

Blood Pressure
|November 1, 2005
PubMed

Insights

Hypertension management after hospitalization for ischemic heart disease (IHD) is suboptimal. Factors like irregular health checks and alcohol use impact treatment, while age and awareness affect blood pressure control.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Public Health

Background:

  • Hypertension is a significant risk factor for ischemic heart disease (IHD).
  • Effective hypertension management is crucial for secondary prevention in IHD patients.
  • Limited data exists on factors influencing hypertension control in IHD survivors.

Purpose of the Study:

  • To investigate factors associated with hypertension management in patients hospitalized for IHD.
  • To identify predictors of suboptimal blood pressure control post-discharge.

Main Methods:

  • Retrospective review of 1051 IHD patient records (myocardial infarction, unstable angina, PCI, CABG).
  • Follow-up interviews conducted 6-18 months post-discharge.
  • Statistical analysis to identify factors influencing hypertension diagnosis, treatment, and control.

Main Results:

  • 70.2% of patients had hypertension; 17.5% were undiagnosed during hospitalization.
  • 7.1% of hypertensive patients received no antihypertensive medication.
  • Irregular health checks, alcohol use, and unstable angina predicted lack of medication.
  • Older age and hypertension awareness predicted uncontrolled hypertension.

Conclusions:

  • Hypertension management in IHD secondary prevention requires improvement.
  • Age and patient awareness are key determinants of blood pressure control quality post-discharge.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...